| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/13/2009 | CN101432265A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432262A Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101429115A Process for producing trifluoro benzene acetic acid and sitagliptin |
| 05/13/2009 | CN100486977C Novel preparation method of ramosetron hydrochloride |
| 05/13/2009 | CN100486976C Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/12/2009 | US7531665 Kinase inhibitors for the treatment of disease |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531661 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 05/12/2009 | US7531656 Synthesis of gatifloxacin |
| 05/12/2009 | US7531654 Process for producing substituted aniline compound |
| 05/12/2009 | US7531568 e.g. [5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yloxy]-acetic acid; peroxisome proliferator activated receptor agonist; anticoagulant, antidiabetic agent; obesity, hyperlipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema, psoriasis |
| 05/12/2009 | US7531566 Anti-inflammatory medicaments |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531552 antiviral for HIV and AIDS; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-(4-fluoro-1H-indol-3-yl)-2-oxo-acetamide; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-acetamide |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531539 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/12/2009 | CA2324921C Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009058924A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058923A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058921A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058919A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058653A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009058300A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | WO2009058120A1 Nicotinic acetylcholine receptor modulators |
| 05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/07/2009 | WO2009058051A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057811A2 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057139A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056625A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009035295A3 Organic compound, and organic photoelectric device including the same |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008155081A3 Substituted aromatic heterocyclic compounds as fungicides |
| 05/07/2009 | WO2008103314A3 Methods for modulating bone formation and mineralization |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 05/07/2009 | US20090118510 Dark coloured azo dyes |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118312 flavivirus antivirals based on1,6-diazacyclotetradecane with fused pyrrolidine or cyclopentane ring at positions 3,4 and methylene bridge at positions 7,8; macrocyclic ring substituted with quinazolin-4-yloxy substituent on the fused pyrrolidine or cyclopentane ring |
| 05/07/2009 | US20090118307 Aryl Sulfonamides |
| 05/07/2009 | US20090118301 Compositions and Methods for Treating Cancer |
| 05/07/2009 | US20090118300 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 05/07/2009 | US20090118284 Novel compounds that are ERK inhibitors |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118273 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/07/2009 | US20090118261 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/07/2009 | US20090118260 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 05/07/2009 | US20090118259 Pharmaceutical use of substituted amides |
| 05/07/2009 | US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090118159 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt thereof; chemical synthesis to obtain antidiabetic agent |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090114355 Organic fluorescent compositions |
| 05/07/2009 | CA2704533A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | CA2703767A1 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | CA2703240A1 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | CA2702320A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2054395A2 Piperazine compounds with a herbicidal action |
| 05/06/2009 | EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1569902B1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | EP1268421B1 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101426786A Benzazole potentiators of metabotropic glutamate receptors |
| 05/06/2009 | CN101426785A Adenosine A3 receptor agonists |
| 05/06/2009 | CN101426784A Novel method for producing pyrimidine compound |
| 05/06/2009 | CN101426783A Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426781A CCR5 antagonists useful for treating HIV |
| 05/06/2009 | CN101426780A Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426778A N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/06/2009 | CN101426777A Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426769A Five-membered heterocyclic invertebrate pest control agents |
| 05/06/2009 | CN101426766A Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423514A Heterocycle substituted triazole compound and synthetic method thereof |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN101422150A New use of prodigiosin |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |